bdm deal with cdc on h5n1 bird flu, page-14

re: bdm deal with cdc on h5n1 bird flu shaolintrad
"Peramivir is a realistic competitor to IV Relenza, but Relenza has a definite head start."

Another product based on stolen neuramidase crystals, part of Biota's IP.

Johnson & Johnson gave them the flick years ago because of lack of potency. Now they trying to reinvent the wheel.

Lets get serious if you got a lock and you make a matching key. There is only one matching key. Any other key has to be a non-perfect match. Relenza was engineered for the perfect match to lock up the neuramidase enzyme.